Articles related to BIPOLAR DISORDER

Lithium continues to be recognized as the most reliable mood stabilizer for bipolar disorder patients with a history of mania, necessitating precise management of dosages to prevent significant side effects.

This recent Supreme Court ruling sheds light on the critical intersection of mental health and legal standards, offering an essential perspective for healthcare professionals involved in forensic or psychiatric fields.

Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.

Lamotrigine stands out for its efficacy in preventing depressive episodes in bipolar I disorder, offering a nuanced option for mood stabilization with an antidepressant emphasis. Understanding its specific clinical applications can enhance treatment strategies for mood disorders.

In a phase 3 study, iloperidone demonstrated a significant improvement in treating bipolar mania, marked by a reduction in the Young Mania Rating Scale (YMRS) scores.

Recent research from the University of Michigan highlights a startling revelation: individuals with bipolar disorder face a mortality risk 4-6 times higher than those without the condition, emphasizing the urgent need for targeted healthcare strategies.